Sara ovejero-Merino, PhD1*, Julie Devin, PharmD2*, Tatiana Cañeque3*, Laura Alibert4*, Guilhem Requirand5*, Nicolas Robert5*, Alizée Steer, PhD6,7*, Amelie Machura7*, Christophe Hirtz8*, Angélique Bruyer6,7*, Laure Vincent, MD9*, Guillaume Cartron, MD, PhD10*, Charles Herbaux11,12,13,14, Raphael Rodriguez3*, Caroline Bret, PhD, PharmD6,15,16* and Jerome Moreaux, PhD5,6,17,18
1Institute of Human Genetics, Montpellier, FRA
2CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France
3Institut Curie, Paris, France
4Institute of human genetics, Montpellier, France
5Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier, Montpellier, France
6Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France
7Diag2Tec, Montpellier, France
8CHU Montpellier, Laboratory of Biochemistry – Clinical Proteomic, Montpellier, France
9Department of Hematology, Montpellier University Hospital, Montpellier, France
10Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
11Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
12University of Montpellier, Paris, France
13University of Montpellier, Montpellier, France
14CHU de Montpellier, Montpellier, France
15Department of Biological Hematology, CHU Montpellier, Montpellier, France
16University of Montpellier, UFR Medecine, Montpellier, France
17UFR Médecine, Université Montpellier, Montpellier, France
18Institut Universitaire de France, Paris, France